Eye Department, Skaraborg Hospital, Karolinska Institute, Lövängsvägen, 541 84, Skövde, Sweden,
Graefes Arch Clin Exp Ophthalmol. 2014 Feb;252(2):315-20. doi: 10.1007/s00417-013-2522-1. Epub 2013 Nov 21.
The aim of this work was to study the reduction in intraocular pressure (IOP) after two selective laser trabeculoplasty (SLT) treatments in the same area of the trabecular meshwork (TM) compared to two SLT treatments in two different areas of the TM when the initial SLT treatment has failed.
This was a prospective randomized clinical trial for testing the effect of repeated SLT treatments in reducing IOP. The patients in the study all suffered from primary open-angle or pseudoexfoliation glaucoma. All patients were treated initially with SLT (SLT 1) over 180° in the lower half of the TM. Patients who were chosen for retreatment with SLT (SLT 2) were asked to participate in the study. The patients in the study were randomized to either SLT 2 in the same, already-treated TM area or to SLT 2 in the upper untreated TM area. The IOP was measured before and 2 h, 1 month, 3 months, and 6 months after the SLT 2 treatment. Patients who changed medical therapy regimens during this time were excluded.
A total of 40 patients were included in both groups. At baseline, there were no significant differences between the groups in regards to age (t-test, p = 0.44), gender (χ(2), p = 0.14), pseudoexfoliation glaucoma (χ(2), p = 0.07), time between SLT 1 and SLT 2 (t-test, p = 0.78), IOP before SLT 1 (t-test, p = 0.78), or IOP before SLT 2 (t-test, p = 0.32). At the conclusion of the study, there were no significant differences in IOP between the groups 2 h (t-test, p = 0.65), 1 month (t-test, p = 0.60), 3 months (t-test, p = 0.42), or 6 months (t-test, p = 0.66) after the SLT 2 treatment.
Two SLT treatments of the same TM area do not have a significant effect on IOP compared to two SLT treatments in two different areas.
本研究旨在探讨当初次选择性激光小梁成形术(SLT)治疗失败后,对同一滤帘区域进行两次 SLT 治疗与对两个不同滤帘区域进行两次 SLT 治疗相比,眼压(IOP)降低情况。
这是一项前瞻性随机临床试验,旨在检验重复 SLT 治疗降低 IOP 的效果。研究中的患者均患有原发性开角型或假性剥脱性青光眼。所有患者均首先在滤帘下半部分接受 180° SLT(SLT1)治疗。选择接受重复 SLT(SLT2)治疗的患者被纳入研究。将这些患者随机分为 SLT2 治疗同一已治疗滤帘区域或 SLT2 治疗上半未治疗滤帘区域。在 SLT2 治疗前、2 小时、1 个月、3 个月和 6 个月时测量 IOP。在此期间改变药物治疗方案的患者被排除在外。
共有 40 例患者被纳入两组。基线时,两组在年龄(t 检验,p=0.44)、性别(卡方检验,p=0.14)、假性剥脱性青光眼(卡方检验,p=0.07)、SLT1 与 SLT2 之间的时间(t 检验,p=0.78)、SLT1 前的 IOP(t 检验,p=0.78)或 SLT2 前的 IOP(t 检验,p=0.32)方面均无显著差异。研究结束时,两组在 SLT2 治疗后 2 小时(t 检验,p=0.65)、1 个月(t 检验,p=0.60)、3 个月(t 检验,p=0.42)和 6 个月(t 检验,p=0.66)时的 IOP 无显著差异。
与对两个不同滤帘区域进行两次 SLT 治疗相比,对同一滤帘区域进行两次 SLT 治疗对 IOP 没有显著影响。